NMS · Medical - Devices

OM (OM) Stock

$4.66 -1.96% NMS: OM Healthcare

Valuation

MetricValue
Price$4.66
Market Cap$86.32M
P/E Ratio-0.87
P/B Ratio0.68
P/S Ratio0.59
EPS (TTM)$-5.37
52-Week High$21.36
52-Week Low$3.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-64.57%
ROA-31.06%
ROCE-53.17%
Gross Margin-56.30%
Operating Margin-56.30%
Net Margin-63.65%
Debt/Equity0.04
Current Ratio6.61

Annual Financials (USD)

Metric20212022202320242025
Revenue$103.0M$115.0M$130.0M$114.0M$119.0M
Operating Profit$-131.0M$-161.0M$-170.0M$-113.0M$-67.0M
Net Profit$-132.0M$-163.0M$-173.0M$-128.0M$-82.0M
EPS$-43.41$-50.75$-52.27$-36.95$-5.37
Op Margin-127.2%-139.6%-130.2%-99.7%-55.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$463.0M$400.0M$314.0M$276.0M$264.0M
Total Liabilities$89.0M$154.0M$191.0M$249.0M$138.0M
Cash$182.0M$73.0M$69.0M$124.0M$35.0M
Borrowings$38.0M$103.0M$136.0M$202.0M$105.0M

Latest News

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jul 2, 2026 Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains? Zacks · Jun 19, 2026 Here’s Why Outset Medical (OM) Rebound Sharply After Last Quarter’s Selloff Insider Monkey · May 13, 2026 Outset Medical to Present at RBC Global Healthcare Conference GlobeNewswire · May 11, 2026 Outset Medical (OM) Q4 2025 Earnings Transcript Motley Fool · May 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-130.0M$-146.0M$-131.0M$-116.0M$-46.0M
Investing Cash Flow$-146.0M$-75.0M$80.0M$103.0M$-98.0M
Financing Cash Flow$11.0M$0$0$-1.0M$0
Net Cash Flow$-113.0M$-139.0M$-5.0M$56.0M$-89.0M
Free Cash Flow$-133.0M$-154.0M$-135.0M$-117.0M$-47.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-49.66%
Quick Ratio4.97
Interest Coverage-4.79
Return 1Y-75.66%
Return 3Y-98.47%
Return 5Y-99.31%

Ownership

Insiders Held5.07%
Institutions Held83.26%
Institutions Float Held87.71%
Institutional HolderSharesReport Date
FMR, LLC2,741,6732026-03-31
BML Capital Management, LLC1,902,2012026-03-31
Blackrock Inc.1,263,2192026-03-31
Bank of America Corporation949,3972026-03-31
Perceptive Advisors Llc833,3332026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CATX $3.00 +1.01% -2.59 $342.14M 0.00%
HSDT $1.69 +0.60% -1.25 $98.67M 0.00%
INGN $6.49 +1.09% -8.00 $175.71M 0.00%
NNOX $1.06 +3.92% -1.56 $73.78M 0.00%
OMIOwens & Minor, Inc. $2.68 +8.94% 14.39 $207.07M 0.00%

About OM

OM is led by CEO Leslie L. Trigg, employs 354 people, headquartered in US, publicly traded since 2020.

OM stock trades at $4.66 with a market capitalization of $86.32M. The stock is valued at a price-to-earnings (P/E) ratio of -0.87, price-to-book of 0.68, price-to-sales of 0.59. Over the past 52 weeks the stock has ranged between $3.00 and $21.36, and currently trades 78.2% below its 52-week high.

On profitability, OM generates a return on equity (ROE) of -64.57%, return on capital employed of -53.17%, an operating margin of -56.30%, a net profit margin of -63.65%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides